Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thermonuclease, commonly referred to as Nuc1 or micrococcal nuclease, is a major extracellular enzyme and critical virulence factor secreted by Staphylococcus aureus [6, 12]. Its primary biological function is the non-specific hydrolysis of both DNA and RNA into mono- and oligonucleotides [9, 10]. In the host environment, Nuc1 facilitates immune evasion by degrading the DNA backbone of neutrophil extracellular traps (NETs), which are web-like structures deployed by the host to entrap and kill pathogens [6, 21]. By destroying these traps, Nuc1 enables the bacterium to escape host killing and contributes to the persistence and dissemination of the infection [9, 10]. Additionally, Nuc1 plays a role in the modulation of biofilm formation and dispersal by regulating the levels of extracellular DNA (eDNA) within the biofilm matrix [8, 14]. From a therapeutic perspective, Nuc1 is an attractive anti-virulence target. Inhibition of its production or activity can disarm the bacteria and enhance host clearance without the selective pressure of traditional bactericidal antibiotics [6, 10]. Clinical agents such as clindamycin have been shown to downregulate nuc1 transcription at sub-inhibitory concentrations, while intravenous immunoglobulin (IVIG) contains neutralizing antibodies that can directly inhibit the enzyme's activity [6, 10]. Furthermore, the high conservation of the nuc gene across S. aureus strains makes it a definitive biomarker for rapid molecular diagnosis in clinical settings [1, 18].
Inhibition of thermonuclease expression or enzymatic activity prevents the degradation of host-derived neutrophil extracellular traps (NETs), thereby restoring the ability of the innate immune system to entrap and clear the bacterial pathogen.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thermonuclease (Nuc1) (Nuc1).